Lipid Profiles and Lipid-Lowering Therapy at the Time of Acute Myocardial Infarction
Mohammed Essa, Qifan Wu, Yuan Lu, Nihar R Desai, Erica S Spatz, Abdel R Dajani, Michael Mankbadi, Bradley Kay, Kamil F Faridi · 2026
Read Lipid Profiles and Lipid-Lowering Therapy at the Time of Acute Myocardial Infarction by Mohammed Essa, Qifan Wu, Yuan Lu, Nihar R Desai, Erica S Spatz, Abdel R Dajani, Michael Mankbadi, Bradley Kay, Kamil F Faridi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13482206.txt.
Description
Mohammed Essa and co-authors review fat levels in the blood and the use of fat lowering drugs when patients reach hospital with a heart attack, in work dated 2026. Lowering one key blood fat is a base step in guarding against heart and vessel disease. The team asked how well that guard was in place at the time of the attack.
Records covered patients admitted from March 2018 to August 2022. Among those with no prior heart disease, most had fat levels above target and only a third were on statin drugs. Many who took no drug had in fact met the rules for one. Gaps also showed in patients with prior disease.
Catalog record
| CREATOR | Mohammed Essa, Qifan Wu, Yuan Lu, Nihar R Desai, Erica S Spatz, Abdel R Dajani, Michael Mankbadi, Bradley Kay, Kamil F Faridi |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 31 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |